Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Capital Leases (2021 - 2026)

Nutex Health (NUTX) has disclosed Capital Leases for 6 consecutive years, with $268.8 million as the latest value for Q1 2026.

  • For Q1 2026, Capital Leases rose 4.02% year-over-year to $268.8 million; the TTM value through Mar 2026 reached $268.8 million, up 4.02%, while the annual FY2025 figure was $268.9 million, 3.62% up from the prior year.
  • Capital Leases hit $268.8 million in Q1 2026 for Nutex Health, roughly flat from $268.9 million in the prior quarter.
  • Across five years, Capital Leases topped out at $270.1 million in Q3 2025 and bottomed at $192.5 million in Q2 2022.
  • Average Capital Leases over 5 years is $236.5 million, with a median of $233.9 million recorded in 2024.
  • Year-over-year, Capital Leases surged 209.76% in 2022 and then decreased 8.67% in 2024.
  • Nutex Health's Capital Leases stood at $203.6 million in 2022, then grew by 5.04% to $213.9 million in 2023, then rose by 21.32% to $259.5 million in 2024, then grew by 3.62% to $268.9 million in 2025, then fell by 0.04% to $268.8 million in 2026.
  • According to Business Quant data, Capital Leases over the past three periods came in at $268.8 million, $268.9 million, and $270.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.